The DOI matches its Crossref record; 195 of the 195 references it cites were found in a registry or an index.
Radiotherapy combination opportunities leveraging immunity for the next oncology practice
Open accessAbstract
Approximately one‐half of patients with newly diagnosed cancer and many patients with persistent or recurrent tumors receive radiotherapy (RT), with the explicit goal of eliminating tumors through direct killing. The current RT dose and schedule regimens have been empirically developed. Although early clinical studies revealed that RT could provoke important responses not only at the site of treatment but also on remote, nonirradiated tumor deposits—the so‐called “abscopal effect”— the underlying mechanisms were poorly understood and were not therapeutically exploited. Recent work has elucidated the immune mechanisms underlying these effects and has paved the way for developing combinations of RT with immune therapy. In the wake of recent therapeutic breakthroughs in the field of immunotherapy, rational combinations of immunotherapy with RT could profoundly change the standard of care for many tumor types in the next decade. Thus, a deep understanding of the immunologic effects of RT is urgently needed to design the next generation of therapeutic combinations. Here, the authors review the immune mechanisms of tumor radiation and summarize the preclinical and clinical evidence on immunotherapy‐RT combinations. Furthermore, a framework is provided for the practicing clinician and the clinician investigator to guide the development of novel combinations to more rapidly advance this important field. CA Cancer J Clin 2017;67:65–85. © 2016 American Cancer Society .
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
Hodi, F. S., O'Day, S. J., McDermott, D. F., Weber, R. W., Sosman, J. A., Haanen, J. B., Gonzalez, R., Robert, C., Schadendorf, D., Hassel, J. C., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003466 · Cited by 15,155
Safety, activity, and immune correlates of anti–PD-1 antibody in cancer
Topalian, S. L., Hodi, F. S., Brahmer, J. R., Gettinger, S. N., Smith, D. C., McDermott, D. F., Powderly, J. D., Carvajal, R. D., Sosman, J. A., Atkins, M. B., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200690 · Cited by 12,628
Pathogen Recognition and Innate Immunity
Akira, S., Uematsu, S., & Takeuchi, O. (2006) · Cell · doi:10.1016/j.cell.2006.02.015 · Cited by 11,952
Safety and activity of anti-PD-L1 antibody in patients with advanced cancer
Brahmer, J. R., Tykodi, S. S., Chow, L. Q. M., Hwu, W.-J., Topalian, S. L., Hwu, P., Drake, C. G., Camacho, L. H., Kauh, J., Odunsi, K., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200694 · Cited by 7,945
Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer
Rizvi, N. A., Hellmann, M. D., Snyder, A., Kvistborg, P., Makarov, V., Havel, J. J., Lee, W., Yuan, J., Wong, P., Ho, T. S., et al. (2015) · Science · doi:10.1126/science.aaa1348 · Cited by 7,802
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
Galon, J., Costes, A., Sanchez-Cabo, F., Kirilovsky, A., Mlecnik, B., Lagorce-Pagès, C., Tosolini, M., Camus, M., Berger, A., Wind, P., et al. (2006) · Science · doi:10.1126/science.1129139 · Cited by 6,516
Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer
Garon, E. B., Rizvi, N. A., Hui, R., Leighl, N., Balmanoukian, A. S., Eder, J. P., Patnaik, A., Aggarwal, C., Gubens, M., Horn, L., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1501824 · Cited by 6,198
Pembrolizumab versus Ipilimumab in Advanced Melanoma
Robert, C., Schachter, J., Long, G. V., Arance, A., Grob, J. J., Mortier, L., Daud, A., Carlino, M. S., McNeil, C., Lotem, M., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1503093 · Cited by 5,887
Curiel, T. J., Coukos, G., Zou, L., Alvarez, X., Cheng, P., Mottram, P., Evdemon-Hogan, M., Conejo-Garcia, J. R., Zhang, L., Burow, M., et al. (2004) · Nature Medicine · doi:10.1038/nm1093 · Cited by 5,151
Self-citationNeoantigens in cancer immunotherapy
Schumacher, T. N., & Schreiber, R. D. (2015) · Science · doi:10.1126/science.aaa4971 · Cited by 4,783
Chen, W., Jin, W., Hardegen, N., Lei, K.-J., Li, L., Marinos, N., McGrady, G., & Wahl, S. M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030152 · Cited by 4,699
Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
Snyder, A., Makarov, V., Merghoub, T., Yuan, J., Zaretsky, J. M., Desrichard, A., Walsh, L. A., Postow, M. A., Wong, P., Ho, T. S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1406498 · Cited by 4,286
Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer
Zhang, L., Conejo-Garcia, J. R., Katsaros, D., Gimotty, P. A., Massobrio, M., Regnani, G., Makrigiannakis, A., Gray, H., Schlienger, K., Liebman, M. N., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020177 · Cited by 3,397
Self-citationCalreticulin exposure dictates the immunogenicity of cancer cell death
Obeid, M., Tesniere, A., Ghiringhelli, F., Fimia, G. M., Apetoh, L., Perfettini, J.-L., Castedo, M., Mignot, G., Panaretakis, T., Casares, N., et al. (2007) · Nature Medicine · doi:10.1038/nm1523 · Cited by 3,216
Apetoh, L., Ghiringhelli, F., Tesniere, A., Obeid, M., Ortiz, C., Criollo, A., Mignot, G., Maiuri, M. C., Ullrich, E., Saulnier, P., et al. (2007) · Nature Medicine · doi:10.1038/nm1622 · Cited by 3,056 · cited 1×
“Furthermore, a TLR4 polymorphism (Asp299Gly) that affects binding to HMGB1 predicted early relapse after RT and anthracyclinebased chemotherapy in patients with breast cancer.(43,45) Interestingly, the abscopal effect of radiation does not occur in tumor protein 53 (p53)-deficient animals.”
BackgroundSelf-citationCTLA-4 Control over Foxp3 + Regulatory T Cell Function
Wing, K., Onishi, Y., Prieto-Martin, P., Yamaguchi, T., Miyara, M., Fehervari, Z., Nomura, T., & Sakaguchi, S. (2008) · Science · doi:10.1126/science.1160062 · Cited by 2,956
PD-L2 is a second ligand for PD-1 and inhibits T cell activation
Latchman, Y., Wood, C. R., Chernova, T., Chaudhary, D., Borde, M., Chernova, I., Iwai, Y., Long, A. J., Brown, J. A., Nunes, R., et al. (2001) · Nature Immunology · doi:10.1038/85330 · Cited by 2,955
Weber, J. S., D'Angelo, S. P., Minor, D., Hodi, F. S., Gutzmer, R., Neyns, B., Hoeller, C., Khushalani, N. I., Miller, W. H., Lao, C. D., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)70076-8 · Cited by 2,676
Hellman, S., & Weichselbaum, R. R. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.1.8 · Cited by 2,562
Dong, H., Zhu, G., Tamada, K., & Chen, L. (1999) · Nature Medicine · doi:10.1038/70932 · Cited by 2,496
Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer
Twyman-Saint Victor, C., Rech, A. J., Maity, A., Rengan, R., Pauken, K. E., Stelekati, E., Benci, J. L., Xu, B., Dada, H., Odorizzi, P. M., et al. (2015) · Nature · doi:10.1038/nature14292 · Cited by 2,434
Topalian, S. L., Sznol, M., McDermott, D. F., Kluger, H. M., Carvajal, R. D., Sharfman, W. H., Brahmer, J. R., Lawrence, D. P., Atkins, M. B., Powderly, J. D., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.53.0105 · Cited by 2,222
Deng, L., Liang, H., Xu, M., Yang, X., Burnette, B., Arina, A., Li, X.-D., Mauceri, H., Beckett, M., Darga, T., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.10.019 · Cited by 2,182
Irradiation and anti–PD-L1 treatment synergistically promote antitumor immunity in mice
Deng, L., Liang, H., Burnette, B., Beckett, M., Darga, T., Weichselbaum, R. R., & Fu, Y.-X. (2014) · Journal of Clinical Investigation · doi:10.1172/jci67313 · Cited by 2,105
Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma
Postow, M. A., Callahan, M. K., Barker, C. A., Yamada, Y., Yuan, J., Kitano, S., Mu, Z., Rasalan, T., Adamow, M., Ritter, E., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1112824 · Cited by 2,087
Reits, E. A., Hodge, J. W., Herberts, C. A., Groothuis, T. A., Chakraborty, M., K.Wansley, E., Camphausen, K., Luiten, R. M., de Ru, A. H., Neijssen, J., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052494 · Cited by 1,737
A Comparison of Etanercept and Methotrexate in Patients with Early Rheumatoid Arthritis
Bathon, J. M., Martin, R. W., Fleischmann, R. M., Tesser, J. R., Schiff, M. H., Keystone, E. C., Genovese, M. C., Wasko, M. C., Moreland, L. W., Weaver, A. L., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011303432201 · Cited by 1,730
Molecular identification of a danger signal that alerts the immune system to dying cells
Shi, Y., Evans, J. E., & Rock, K. L. (2003) · Nature · doi:10.1038/nature01991 · Cited by 1,684
Dewan, M. Z., Galloway, A. E., Kawashima, N., Dewyngaert, J. K., Babb, J. S., Formenti, S. C., & Demaria, S. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0265 · Cited by 1,678
CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans
Beatty, G. L., Chiorean, E. G., Fishman, M. P., Saboury, B., Teitelbaum, U. R., Sun, W., Huhn, R. D., Song, W., Li, D., Sharp, L. L., et al. (2011) · Science · doi:10.1126/science.1198443 · Cited by 1,672
Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance
Elliott, M. R., Chekeni, F. B., Trampont, P. C., Lazarowski, E. R., Kadl, A., Walk, S. F., Park, D., Woodson, R. I., Ostankovich, M., Sharma, P., et al. (2009) · Nature · doi:10.1038/nature08296 · Cited by 1,654
Loi, S., Sirtaine, N., Piette, F., Salgado, R., Viale, G., Van Eenoo, F., Rouas, G., Francis, P., Crown, J. P. A., Hitre, E., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2011.41.0902 · Cited by 1,632
Immunological effects of conventional chemotherapy and targeted anticancer agents
Galluzzi, L., Buqué, A., Kepp, O., Zitvogel, L., & Kroemer, G. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.10.012 · Cited by 1,530
Kwon, E. D., Drake, C. G., Scher, H. I., Fizazi, K., Bossi, A., van den Eertwegh, A. J. M., Krainer, M., Houede, N., Santos, R., Mahammedi, H., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70189-5 · Cited by 1,511
Gardai, S. J., McPhillips, K. A., Frasch, S. C., Janssen, W. J., Starefeldt, A., Murphy-Ullrich, J. E., Bratton, D. L., Oldenborg, P.-A., Michalak, M., & Henson, P. M. (2005) · Cell · doi:10.1016/j.cell.2005.08.032 · Cited by 1,473
Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated
Demaria, S., Ng, B., Devitt, M. L., Babb, J. S., Kawashima, N., Liebes, L., & Formenti, S. C. (2004) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2003.09.012 · Cited by 1,388
Autophagy-Dependent Anticancer Immune Responses Induced by Chemotherapeutic Agents in Mice
Michaud, M., Martins, I., Sukkurwala, A. Q., Adjemian, S., Ma, Y., Pellegatti, P., Shen, S., Kepp, O., Scoazec, M., Mignot, G., et al. (2011) · Science · doi:10.1126/science.1208347 · Cited by 1,377
Dudley, M. E., Yang, J. C., Sherry, R., Hughes, M. S., Royal, R., Kammula, U., Robbins, P. F., Huang, J., Citrin, D. E., Leitman, S. F., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.5449 · Cited by 1,332
Lee, Y., Auh, S. L., Wang, Y., Burnette, B., Wang, Y., Meng, Y., Beckett, M., Sharma, R., Chin, R., Tu, T., et al. (2009) · Blood · doi:10.1182/blood-2009-02-206870 · Cited by 1,324
Gooden, M. J. M., de Bock, G. H., Leffers, N., Daemen, T., & Nijman, H. W. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.189 · Cited by 1,277
Rodriguez, P. C., Quiceno, D. G., Zabaleta, J., Ortiz, B., Zea, A. H., Piazuelo, M. B., Delgado, A., Correa, P., Brayer, J., Sotomayor, E. M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0465 · Cited by 1,276
Munn, D. H., Sharma, M. D., Baban, B., Harding, H. P., Zhang, Y., Ron, D., & Mellor, A. L. (2005) · Immunity · doi:10.1016/j.immuni.2005.03.013 · Cited by 1,272
Vincent, J., Mignot, G., Chalmin, F., Ladoire, S., Bruchard, M., Chevriaux, A., Martin, F., Apetoh, L., Rébé, C., & Ghiringhelli, F. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3690 · Cited by 1,245
Fuertes, M. B., Kacha, A. K., Kline, J., Woo, S.-R., Kranz, D. M., Murphy, K. M., & Gajewski, T. F. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20101159 · Cited by 1,192
Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing
Yadav, M., Jhunjhunwala, S., Phung, Q. T., Lupardus, P., Tanguay, J., Bumbaca, S., Franci, C., Cheung, T. K., Fritsche, J., Weinschenk, T., et al. (2014) · Nature · doi:10.1038/nature14001 · Cited by 1,186
Immunogenic death of colon cancer cells treated with oxaliplatin
Tesniere, A., Schlemmer, F., Boige, V, Kepp, O., Martins, I., Ghiringhelli, F., Aymeric, L., Michaud, M., Apetoh, L., Barault, L., et al. (2010) · Oncogene · doi:10.1038/onc.2009.356 · Cited by 1,173
Melief, C. J. M., van Hall, T., Arens, R., Ossendorp, F., & van der Burg, S. H. (2015) · Journal of Clinical Investigation · doi:10.1172/jci80009 · Cited by 1,164
Whole Body Irradiation—Radiobiology or Medicine?
Mole, R. H. (1953) · The British Journal of Radiology · doi:10.1259/0007-1285-26-305-234 · Cited by 1,123
Pannexin 1 channels mediate ‘find-me’ signal release and membrane permeability during apoptosis
Chekeni, F. B., Elliott, M. R., Sandilos, J. K., Walk, S. F., Kinchen, J. M., Lazarowski, E. R., Armstrong, A. J., Penuela, S., Laird, D. W., Salvesen, G. S., et al. (2010) · Nature · doi:10.1038/nature09413 · Cited by 1,120
Klug, F., Prakash, H., Huber, P. E., Seibel, T., Bender, N., Halama, N., Pfirschke, C., Voss, R. H., Timke, C., Umansky, L., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.09.014 · Cited by 1,099
Immune infiltration in human tumors: a prognostic factor that should not be ignored
Pagès, F., Galon, J., Dieu-Nosjean, M.-C., Tartour, E., Sautès-Fridman, C., & Fridman, W.-H. (2010) · Oncogene · doi:10.1038/onc.2009.416 · Cited by 1,087
Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Lung Metastases
Rusthoven, K. E., Kavanagh, B. D., Burri, S. H., Chen, C., Cardenes, H., Chidel, M. A., Pugh, T. J., Kane, M., Gaspar, L. E., & Schefter, T. E. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.6386 · Cited by 1,082
Macrophage Regulation of Tumor Responses to Anticancer Therapies
De Palma, M., & Lewis, C. E. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.02.013 · Cited by 1,079
Robbins, P. F., Lu, Y.-C., El-Gamil, M., Li, Y. F., Gross, C., Gartner, J., Lin, J. C., Teer, J. K., Cliften, P., Tycksen, E., et al. (2013) · Nature Medicine · doi:10.1038/nm.3161 · Cited by 1,072
Gattinoni, L., Finkelstein, S. E., Klebanoff, C. A., Antony, P. A., Palmer, D. C., Spiess, P. J., Hwang, L. N., Yu, Z., Wrzesinski, C., Heimann, D. M., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050732 · Cited by 1,061
Demaria, S., Kawashima, N., Yang, A. M., Devitt, M. L., Babb, J. S., Allison, J. P., & Formenti, S. C. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.728.11.2 · Cited by 1,022
Lynch, T. J., Bondarenko, I., Luft, A., Serwatowski, P., Barlesi, F., Chacko, R., Sebastian, M., Neal, J., Lu, H., Cuillerot, J.-M., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.38.4032 · Cited by 1,002
Ghiringhelli, F., Ménard, C., Terme, M., Flament, C., Taieb, J., Chaput, N., Puig, P. E., Novault, S., Escudier, B., Vivier, E., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051511 · Cited by 949
Zeng, J., See, A. P., Phallen, J., Jackson, C. M., Belcaid, Z., Ruzevick, J., Durham, N., Meyer, C., Harris, T. J., Albesiano, E., et al. (2013) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2012.12.025 · Cited by 889
Burnette, B. C., Liang, H., Lee, Y., Chlewicki, L., Khodarev, N. N., Weichselbaum, R. R., Fu, Y.-X., & Auh, S. L. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2820 · Cited by 878
Selby, M. J., Engelhardt, J. J., Quigley, M., Henning, K. A., Chen, T., Srinivasan, M., & Korman, A. J. (2013) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-13-0013 · Cited by 857
Mechanisms of pre‐apoptotic calreticulin exposure in immunogenic cell death
Panaretakis, T., Kepp, O., Brockmeier, U., Tesniere, A., Bjorklund, A., Chapman, D. C., Durchschlag, M., Joza, N., Pierron, G., van Endert, P., et al. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.1 · Cited by 848
A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death
Garg, A. D., Krysko, D. V., Verfaillie, T., Kaczmarek, A., Ferreira, G. B., Marysael, T., Rubio, N., Firczuk, M., Mathieu, C., Roebroek, A. J. M., et al. (2012) · The EMBO Journal · doi:10.1038/emboj.2011.497 · Cited by 800
Chao, M. P., Jaiswal, S., Weissman-Tsukamoto, R., Alizadeh, A. A., Gentles, A. J., Volkmer, J., Weiskopf, K., Willingham, S. B., Raveh, T., Park, C. Y., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001375 · Cited by 776
Ghiringhelli, F., Puig, P. E., Roux, S., Parcellier, A., Schmitt, E., Solary, E., Kroemer, G., Martin, F., Chauffert, B., & Zitvogel, L. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050463 · Cited by 776
Radiation-Induced CXCL16 Release by Breast Cancer Cells Attracts Effector T Cells
Matsumura, S., Wang, B., Kawashima, N., Braunstein, S., Badura, M., Cameron, T. O., Babb, J. S., Schneider, R. J., Formenti, S. C., Dustin, M. L., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.5.3099 · Cited by 711
Golden, E. B., Demaria, S., Schiff, P. B., Chachoua, A., & Formenti, S. C. (2013) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-13-0115 · Cited by 688
Tumor Immunotherapy Directed at PD-1
Ribas, A. (2012) · New England Journal of Medicine · doi:10.1056/nejme1205943 · Cited by 683
Sharabi, A. B., Nirschl, C. J., Kochel, C. M., Nirschl, T. R., Francica, B. J., Velarde, E., Deweese, T. L., & Drake, C. G. (2015) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-14-0196 · Cited by 658
Lotze, M. T., Zeh, H. J., Rubartelli, A., Sparvero, L. J., Amoscato, A. A., Washburn, N. R., DeVera, M. E., Liang, X., Tör, M., & Billiar, T. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2007.00579.x · Cited by 641
Holmgaard, R. B., Zamarin, D., Munn, D. H., Wolchok, J. D., & Allison, J. P. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20130066 · Cited by 634
Adenosine, an endogenous anti-inflammatory agent
Cronstein, B. N. (1994) · Journal of Applied Physiology · doi:10.1152/jappl.1994.76.1.5 · Cited by 633
Romano, E., Kusio-Kobialka, M., Foukas, P. G., Baumgaertner, P., Meyer, C., Ballabeni, P., Michielin, O., Weide, B., Romero, P., & Speiser, D. E. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1417320112 · Cited by 601
Deciphering and Reversing Tumor Immune Suppression
Motz, G. T., & Coukos, G. (2013) · Immunity · doi:10.1016/j.immuni.2013.07.005 · Cited by 598
Self-citationPaulos, C. M., Wrzesinski, C., Kaiser, Hinrichs, C. S., Chieppa, M., Cassard, L., Palmer, D. C., Boni, A., Muranski, P., Yu, Z., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32205 · Cited by 586 · cited 1×
“ation damage of the intestinal mucosal barrier, transmigration of intestinal flora in the mesenteric lymph nodes, and potent, innate immune activation through microbial TLR4 ligands like lipopolysaccharide.(207) The value of”
BackgroundApetoh, L., Ghiringhelli, F., Tesniere, A., Criollo, A., Ortiz, C., Lidereau, R., Mariette, C., Chaput, N., Mira, J., Delaloge, S., et al. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2007.00573.x · Cited by 574
Low-dose hypersensitivity: current status and possible mechanisms
Joiner, M. C., Marples, B., Lambin, P., Short, S. C., & Turesson, I. (2001) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(00)01471-1 · Cited by 570
Xu, J., Escamilla, J., Mok, S., David, J., Priceman, S., West, B., Bollag, G., McBride, W., & Wu, L. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3981 · Cited by 569
Maximizing Tumor Immunity With Fractionated Radiation
Schaue, D., Ratikan, J. A., Iwamoto, K. S., & McBride, W. H. (2012) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2011.09.049 · Cited by 567
Garnett, C. T., Palena, C., Chakarborty, M., Tsang, K.-Y., Schlom, J., & Hodge, J. W. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1525 · Cited by 557
Butts, C., Socinski, M. A., Mitchell, P. L., Thatcher, N., Havel, L., Krzakowski, M., Nawrocki, S., Ciuleanu, T.-E., Bosquée, L., Trigo, J. M., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70510-2 · Cited by 538
TGFβ is a master regulator of radiation therapy-induced antitumor immunity
Vanpouille-Box, C., Diamond, J. M., Pilones, K. A., Zavadil, J., Babb, J. S., Formenti, S. C., Barcellos-Hoff, M. H., & Demaria, S. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3511 · Cited by 514
Vonderheide, R. H., Flaherty, K. T., Khalil, M., Stumacher, M. S., Bajor, D. L., Hutnick, N. A., Sullivan, P., Mahany, J. J., Gallagher, M., Kramer, A., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.3311 · Cited by 513
Image-guided radiotherapy: from current concept to future perspectives
Jaffray, D. A. (2012) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2012.194 · Cited by 496
In Situ Vaccination With a TLR9 Agonist Induces Systemic Lymphoma Regression: A Phase I/II Study
Brody, J. D., Ai, W. Z., Czerwinski, D. K., Torchia, J. A., Levy, M., Advani, R. H., Kim, Y. H., Hoppe, R. T., Knox, S. J., Shin, L. K., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.9793 · Cited by 487
Radiation-Induced IFN-γ Production within the Tumor Microenvironment Influences Antitumor Immunity
Lugade, A. A., Sorensen, E. W., Gerber, S. A., Moran, J. P., Frelinger, J. G., & Lord, E. M. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.5.3132 · Cited by 485
Obeid, M., Panaretakis, T., Joza, N., Tufi, R., Tesniere, A., van Endert, P., Zitvogel, L., & Kroemer, G. (2007) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402201 · Cited by 474
Filatenkov, A., Baker, J., Mueller, A. M. S., Kenkel, J., Ahn, G.-O., Dutt, S., Zhang, N., Kohrt, H., Jensen, K., Dejbakhsh-Jones, S., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2824 · Cited by 474
Phase I Study of Individualized Stereotactic Body Radiotherapy of Liver Metastases
Lee, M. T., Kim, J. J., Dinniwell, R., Brierley, J., Lockwood, G., Wong, R., Cummings, B., Ringash, J., Tse, R. V., Knox, J. J., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.0600 · Cited by 473
High-Mobility Group Box 1, Oxidative Stress, and Disease
Tang, D., Kang, R., Zeh, H. J., & Lotze, M. T. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3356 · Cited by 468
Chakraborty, M., Abrams, S. I., Camphausen, K., Liu, K., Scott, T., Coleman, C. N., & Hodge, J. W. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.12.6338 · Cited by 467
Ligand-induced conformational changes allosterically activate Toll-like receptor 9
Latz, E., Verma, A., Visintin, A., Gong, M., Sirois, C. M., Klein, D. C. G., Monks, B. G., McKnight, C. J., Lamphier, M. S., Duprex, W. P., et al. (2007) · Nature Immunology · doi:10.1038/ni1479 · Cited by 465
Hailemichael, Y., Dai, Z., Jaffarzad, N., Ye, Y., Medina, M. A., Huang, X.-F., Dorta-Estremera, S. M., Greeley, N. R., Nitti, G., Peng, W., et al. (2013) · Nature Medicine · doi:10.1038/nm.3105 · Cited by 457
Machiels, J.-P., Reilly, R. T., Emens, L. A., Ercolini, A. M., Lei, R. Y., Weintraub, D., Okoye, F. I., & Jaffee, E. M. (2001) · PubMed · Cited by 453
Kynurenine is an endothelium-derived relaxing factor produced during inflammation
Wang, Y., Liu, H., McKenzie, G., Witting, P. K., Stasch, J.-P., Hahn, M., Changsirivathanathamrong, D., Wu, B. J., Ball, H. J., Thomas, S. R., et al. (2010) · Nature Medicine · doi:10.1038/nm.2092 · Cited by 446
Radiotherapy Promotes Tumor-Specific Effector CD8+ T Cells via Dendritic Cell Activation
Gupta, A., Probst, H. C., Vuong, V., Landshammer, A., Muth, S., Yagita, H., Schwendener, R., Pruschy, M., Knuth, A., & van den Broek, M. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200563 · Cited by 446
Chakraborty, M., Abrams, S. I., Coleman, C. N., Camphausen, K., Schlom, J., & Hodge, J. W. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0073 · Cited by 435
Radiation Enhances Regulatory T Cell Representation
Kachikwu, E. L., Iwamoto, K. S., Liao, Y.-P., DeMarco, J. J., Agazaryan, N., Economou, J. S., McBride, W. H., & Schaue, D. (2011) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2010.09.034 · Cited by 429
Iannello, A., Thompson, T. W., Ardolino, M., Lowe, S. W., & Raulet, D. H. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20130783 · Cited by 414
Goff, S. L., Dudley, M. E., Citrin, D. E., Somerville, R. P., Wunderlich, J. R., Danforth, D. N., Zlott, D. A., Yang, J. C., Sherry, R. M., Kammula, U. S., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.66.7220 · Cited by 407
Grimaldi, A. M., Simeone, E., Giannarelli, D., Muto, P., Falivene, S., Borzillo, V., Giugliano, F. M., Sandomenico, F., Petrillo, A., Curvietto, M., et al. (2014) · OncoImmunology · doi:10.4161/onci.28780 · Cited by 379
Gulley, J. L., Arlen, P. M., Bastian, A., Morin, S., Marte, J., Beetham, P., Tsang, K.-Y., Yokokawa, J., Hodge, J. W., Ménard, C., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2062 · Cited by 370
Biswas, S., Guix, M., Rinehart, C., Dugger, T. C., Chytil, A., Moses, H. L., Freeman, M. L., & Arteaga, C. L. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30740 · Cited by 346
The co-translocation of ERp57 and calreticulin determines the immunogenicity of cell death
Panaretakis, T., Joza, N., Modjtahedi, N., Tesniere, A., Vitale, I., Durchschlag, M., Fimia, G. M., Kepp, O., Piacentini, M., Froehlich, K.-U., et al. (2008) · Cell Death & Differentiation · doi:10.1038/cdd.2008.67 · Cited by 344
Phase 1 Study of Stereotactic Body Radiotherapy and Interleukin-2—Tumor and Immunological Responses
Seung, S. K., Curti, B. D., Crittenden, M., Walker, E., Coffey, T., Siebert, J. C., Miller, W., Payne, R., Glenn, L., Bageac, A., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003649 · Cited by 303
Jobling, M. F., Mott, J. D., Finnegan, M. T., Jurukovski, V., Erickson, A. C., Walian, P. J., Taylor, S. E., Ledbetter, S., Lawrence, C. M., Rifkin, D. B., et al. (2006) · Radiation Research · doi:10.1667/rr0695.1 · Cited by 300
Wrzesinski, C., Paulos, C. M., Kaiser, A., Muranski, P., Palmer, D. C., Gattinoni, L., Yu, Z., Rosenberg, S. A., & Restifo, N. P. (2010) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3181b88ffc · Cited by 283
Chinnasamy, D., Yu, Z., Kerkar, S. P., Zhang, L., Morgan, R. A., Restifo, N. P., & Rosenberg, S. A. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-3050 · Cited by 277
Abscopal regression of hepatocellular carcinoma after radiotherapy for bone metastasis
Ohba, K., Omagari, K., Nakamura, T., Ikuno, N., Saeki, S., Matsuo, I., Kinoshita, H., Masuda, J., Hazama, H., Sakamoto, I., et al. (1998) · Gut · doi:10.1136/gut.43.4.575 · Cited by 277
Verbrugge, I., Hagekyriakou, J., Sharp, L. L., Galli, M., West, A., McLaughlin, N. M., Duret, H., Yagita, H., Johnstone, R. W., Smyth, M. J., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0210 · Cited by 275
(1979) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/63.5.1229 · Cited by 263
Brignone, C., Gutierrez, M., Mefti, F., Brain, E., Jarcau, R., Cvitkovic, F., Bousetta, N., Medioni, J., Gligorov, J., Grygar, C., et al. (2010) · Journal of Translational Medicine · doi:10.1186/1479-5876-8-71 · Cited by 255
ATP Acts as an Agonist to Promote Stimulus-Induced Secretion of IL-1β and IL-18 in Human Blood
Perregaux, D. G., McNiff, P., Laliberte, R., Conklyn, M., & Gabel, C. A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.8.4615 · Cited by 255
Radiation abscopal antitumor effect is mediated through p53.
Camphausen, K. A., Moses, M. A., Ménard, C. M., Sproull, M. T., Beecken, W.-D. C., Folkman, J., & O’Reilly, M. S. (2003) · PubMed · Cited by 254
A Systemic Complete Response of Metastatic Melanoma to Local Radiation and Immunotherapy
Hiniker, S. M., Chen, D. S., Reddy, S., Chang, D. T., Jones, J. C., Mollick, J. A., Swetter, S. M., & Knox, S. J. (2012) · Translational Oncology · doi:10.1593/tlo.12280 · Cited by 247
Sevko, A., Michels, T., Vrohlings, M., Umansky, L., Beckhove, P., Kato, M., Shurin, G. V., Shurin, M. R., & Umansky, V. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202781 · Cited by 246
Belcaid, Z., Phallen, J. A., Zeng, J., See, A. P., Mathios, D., Gottschalk, C., Nicholas, S., Kellett, M., Ruzevick, J., Jackson, C., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101764 · Cited by 244
Bouquet, F., Pal, A., Pilones, K. A., Demaria, S., Hann, B., Akhurst, R. J., Babb, J. S., Lonning, S. M., DeWyngaert, J. K., Formenti, S. C., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0544 · Cited by 240
CD91-dependent programming of T-helper cell responses following heat shock protein immunization
Pawaria, S., & Binder, R. J. (2011) · Nature Communications · doi:10.1038/ncomms1524 · Cited by 239
Nowak, A. K., Robinson, B. W. S., & Lake, R. (2002) · PubMed · Cited by 238
Wersäll, P. J., Blomgren, H., Pisa, P., Lax, I., Kälkner, K.-M., & Svedman, C. (2006) · Acta Oncologica · doi:10.1080/02841860600604611 · Cited by 233
The controversial abscopal effect
Kaminski, J. M., Shinohara, E., Summers, J. B., Niermann, K. J., Morimoto, A., & Brousal, J. (2005) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2005.03.004 · Cited by 229
Textor, S., Fiegler, N., Arnold, A., Porgador, A., Hofmann, T. G., & Cerwenka, A. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3211 · Cited by 221
Suzuki, Y., Mimura, K., Yoshimoto, Y., Watanabe, M., Ohkubo, Y., Izawa, S., Murata, K., Fujii, H., Nakano, T., & Kono, K. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0851 · Cited by 219
Vaccination during myeloid cell depletion by cancer chemotherapy fosters robust T cell responses
Welters, M. J., van der Sluis, T. C., van Meir, H., Loof, N. M., van Ham, V. J., van Duikeren, S., Santegoets, S. J., Arens, R., de Kam, M. L., Cohen, A. F., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aad8307 · Cited by 216
Induction of Tumor-specific T Cell Immunity by Anti-DR5 Antibody Therapy
Takeda, K., Yamaguchi, N., Akiba, H., Kojima, Y., Hayakawa, Y., Tanner, J. E., Sayers, T. J., Seki, N., Okumura, K., Yagita, H., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031457 · Cited by 206
Ko, A., Kanehisa, A., Martins, I., Senovilla, L., Chargari, C., Dugue, D., Mariño, G., Kepp, O., Michaud, M., Perfettini, J.-L., et al. (2014) · Cell Death & Differentiation · doi:10.1038/cdd.2013.124 · Cited by 205
Rodel, F., Frey, B., Gaipl, U., Keilholz, L., Fournier, C., Manda, K., Schollnberger, H., Hildebrandt, G., & Rodel, C. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712800099866 · Cited by 194
Suppressing T cell motility induced by anti–CTLA-4 monotherapy improves antitumor effects
Ruocco, M. G., Pilones, K. A., Kawashima, N., Cammer, M., Huang, J., Babb, J. S., Liu, M., Formenti, S. C., Dustin, M. L., & Demaria, S. (2012) · Journal of Clinical Investigation · doi:10.1172/jci61931 · Cited by 187
Induction of cell death by radiotherapy.
Ross, G. M. (1999) · Endocrine-related cancer · doi:10.1677/erc.0.0060041 · Cited by 180
Surace, L., Lysenko, V., Fontana, A. O., Cecconi, V., Janssen, H., Bicvic, A., Okoniewski, M., Pruschy, M., Dummer, R., Neefjes, J., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.03.009 · Cited by 179
VTX-2337 Is a Novel TLR8 Agonist That Activates NK Cells and Augments ADCC
Lu, H., Dietsch, G. N., Matthews, M.-A. H., Yang, Y., Ghanekar, S., Inokuma, M., Suni, M., Maino, V. C., Henderson, K. E., Howbert, J. J., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1625 · Cited by 176
Radioprotection in Normal Tissue and Delayed Tumor Growth by Blockade of CD47 Signaling
Maxhimer, J. B., Soto-Pantoja, D. R., Ridnour, L. A., Shih, H. B., DeGraff, W. G., Tsokos, M., Wink, D. A., Isenberg, J. S., & Roberts, D. D. (2009) · Science Translational Medicine · doi:10.1126/scitranslmed.3000139 · Cited by 175
Single dose of anti–CTLA-4 enhances CD8 + T-cell memory formation, function, and maintenance
Pedicord, V. A., Montalvo, W., Leiner, I. M., & Allison, J. P. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1016791108 · Cited by 174
Standard Treatments Induce Antigen-Specific Immune Responses in Prostate Cancer
Nesslinger, N. J., Sahota, R. A., Stone, B., Johnson, K., Chima, N., King, C., Rasmussen, D., Bishop, D., Rennie, P. S., Gleave, M., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1772 · Cited by 168
An interesting case of possible abscopal effect in malignant melanoma
Kingsley, D. P. E. (1975) · The British Journal of Radiology · doi:10.1259/0007-1285-48-574-863 · Cited by 166
Liang, H., Deng, L., Chmura, S., Burnette, B., Liadis, N., Darga, T., Beckett, M. A., Lingen, M. W., Witt, M., Weichselbaum, R. R., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202612 · Cited by 165
Andarawewa, K. L., Erickson, A. C., Chou, W. S., Costes, S. V., Gascard, P., Mott, J. D., Bissell, M. J., & Barcellos-Hoff, M. H. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1294 · Cited by 161
Dewan, M. Z., Vanpouille‐Box, C., Kawashima, N., DiNapoli, S., Babb, J. S., Formenti, S. C., Adams, S., & Demaria, S. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0984 · Cited by 160
Transforming Growth Factor-β and the Immune Response to Malignant Disease
Teicher, B. A. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1654 · Cited by 159
Mason, K. A., Ariga, H., Neal, R. E., Valdecanas, D. R., Hunter, N. R., Krieg, A. Μ., Whisnant, J. K., & Milas, L. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.361.11.1 · Cited by 153
Ina, Y., Tanooka, H., Yamada, T., & Sakai, K. (2005) · Radiation Research · doi:10.1667/rr3289 · Cited by 152
Radiation Hormesis: Its Expression in the Immune System
Liu, S. Z., Liu, W. H., & Sun, J. B. (1987) · Health Physics · doi:10.1097/00004032-198705000-00008 · Cited by 150
Dovedi, S. J., Melis, M. H. M., Wilkinson, R. W., Adlard, A. L., Stratford, I. J., Honeychurch, J., & Illidge, T. (2012) · Blood · doi:10.1182/blood-2012-05-432393 · Cited by 150
Nemunaitis, J., Nemunaitis, M., Senzer, N., Snitz, P., Bedell, C., Kumar, P., Pappen, B., Maples, P. B., Shawler, D., & Fakhrai, H. (2009) · Cancer Gene Therapy · doi:10.1038/cgt.2009.15 · Cited by 147
Tumor-Derived TGFβ-1 Induces Dendritic Cell Apoptosis in the Sentinel Lymph Node
Ito, M., Minamiya, Y., Kawai, H., Saitô, S., Saito, H., Nakagawa, T., Imai, K., Hirokawa, M., & Ogawa, J. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.9.5637 · Cited by 145
T-Cell Responses to Survivin in Cancer Patients Undergoing Radiation Therapy
Schaue, D., Comin-Anduix, B., Ribas, A., Zhang, L., Goodglick, L., Sayre, J. W., Debucquoy, A., Haustermans, K. M., & McBride, W. H. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4462 · Cited by 145
Li, M., Bolduc, A. R., Hoda, M. N., Gamble, D. N., Dolisca, S.-B., Bolduc, A., Hoang, K., Ashley, C., McCall, D. C., Rojiani, A. M., et al. (2014) · Journal for ImmunoTherapy of Cancer · doi:10.1186/2051-1426-2-21 · Cited by 144
Soluble plasma HLA peptidome as a potential source for cancer biomarkers
Bassani‐Sternberg, M., Barnea, E., Beer, I., Avivi, I. M., Katz, T., & Admon, A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1008501107 · Cited by 129
Yoshimoto, Y., Suzuki, Y., Mimura, K., Ando, K., Oike, T., Sato, H., Okonogi, N., Maruyama, T., Izawa, S., Noda, S., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092572 · Cited by 126
Gamma-Ray Resistance of Regulatory CD4+CD25+Foxp3+ T Cells in Mice
Qu, Y., Jin, S., Zhang, A., Zhang, B., Shi, X.-Y., Wang, J.-J., & Zhao, Y. (2010) · Radiation Research · doi:10.1667/rr0978.1 · Cited by 125
Calveley, V. L., Khan, M. A., Yeung, I. W. T., VanDyk, J., & Hill, R. P. (2005) · International Journal of Radiation Biology · doi:10.1080/09553000600568002 · Cited by 114
Cancer Control Related to Stimulation of Immunity by Low-Dose Radiation
Liu, S. (2007) · Dose-Response · doi:10.2203/dose-response.06-108.liu · Cited by 110
Radojčić, V., Bezak, K. B., Škarica, M., Pletneva, M., Yoshimura, K., Schulick, R. D., & Luznik, L. (2009) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-009-0734-3 · Cited by 108
Premortem autophagy determines the immunogenicity of chemotherapy-induced cancer cell death
Martins, I., Michaud, M., Sukkurwala, A. Q., Adjemian, S., Ma, Y., Shen, S., Kepp, O., Menger, L., Vacchelli, E., Galluzzi, L., et al. (2012) · Autophagy · doi:10.4161/auto.19009 · Cited by 107
Lechleider, R. J., Arlen, P. M., Tsang, K.-Y., Steinberg, S. M., Yokokawa, J., Cereda, V., Camphausen, K. A., Schlom, J., Dahut, W. L., & Gulley, J. L. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-5162 · Cited by 106
γ-Irradiation induces P2X7 receptor-dependent ATP release from B16 melanoma cells
Ohshima, Y., Tsukimoto, M., Takenouchi, T., et al. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.10.008 · Cited by 104
Mangsbo, S. M., Broos, S., Fletcher, E. A. K., Veitonmäki, N., Furebring, C., Dahlén, E., Norlén, P., Lindstedt, M., Tötterman, T. H., & Ellmark, P. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0913 · Cited by 102
Ina, Y., & Sakai, K. (2005) · International Journal of Radiation Biology · doi:10.1080/09553000500519808 · Cited by 101
Huang, Y., Snuderl, M., & Jain, R. K. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.01.005 · Cited by 101
Bartkowiak, T., Singh, S., Yang, G., Sierra, G., Haria, D., Ai, M., Allison, J. P., Sastry, K. J., & Curran, M. A. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1514418112 · Cited by 100
van der Sluis, T. C., van Duikeren, S., Huppelschoten, S., Jordanova, E. S., Nejad, E. B., Sloots, A., Boon, L., Smit, V. T. H. B. M., Welters, M. J. P., OSSENDORP, F. A., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2142 · Cited by 92
Annels, N. E., Shaw, V. E., Gabitass, R. F., Billingham, L. J., Corrie, P. G., Eatock, M. M., Valle, J. W., Smith, D. B., Wadsley, J., Cunningham, D., et al. (2013) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-013-1502-y · Cited by 91
Saito, H., Tsujitani, S., Oka, S., Kondo, A., Ikeguchi, M., Maeta, M., & Kaibara, N. (2000) · PubMed · Cited by 91
Yokouchi, H., Yamazaki, K., Chamoto, K., Kikuchi, E., Shinagawa, N., Oizumi, S., Hommura, F., Nishimura, T., & Nishimura, M. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2007.00664.x · Cited by 90
TLR9 Signaling in the Tumor Microenvironment Initiates Cancer Recurrence after Radiotherapy
Gao, C., Kozłowska, A. K., Nechaev, S., Li, H., Zhang, Q., Hossain, D. M. S., Kowolik, C. M., Chu, P. G., Swiderski, P. M., Diamond, D. J., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-1314 · Cited by 89
Honeychurch, J., Glennie, M. J., Johnson, P., & Illidge, T. (2003) · Blood · doi:10.1182/blood-2002-12-3717 · Cited by 88
Agaugué, S., Perrin‐Cocon, L., Coutant, F., André, P., & Lotteau, V. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.4.2061 · Cited by 87
Wu, X., Feng, Q., Wang, Y., Shi, J., Ge, H., & Di, W. J. (2009) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-009-0749-9 · Cited by 84
Rice, A. E., Latchman, Y. E., Balint, J. P., Lee, J. H., Gabitzsch, E. S., & Jones, F. R. (2015) · Cancer Gene Therapy · doi:10.1038/cgt.2015.40 · Cited by 82
Beal, A. M., Ramos-Hernández, N., Riling, C., Nowelsky, E. A., & Oliver, P. M. (2011) · Nature Immunology · doi:10.1038/ni.2154 · Cited by 73
Nakatsukasa, H., Tsukimoto, M., Tokunaga, A., & Kojima, S. (2010) · Radiation Research · doi:10.1667/rr2121.1 · Cited by 72
Radiotherapy of Human Sarcoma Promotes an Intratumoral Immune Effector Signature
Sharma, A., Bode, B., Studer, G., Moch, H., Okoniewski, M. J., Knuth, A. K., von Boehmer, L., & van den Broek, M. F. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0352 · Cited by 69
Radiotherapy Enhances Antitumor Effect of Anti-CD137 Therapy in a Mouse Glioma Model
Newcomb, E. W., Lukyanov, Y., Kawashima, N., Alonso‐Basanta, M., Wang, S., Liu, M., Jure‐Kunkel, M., Zagzag, D., Demaria, S., & Formenti, S. C. (2010) · Radiation Research · doi:10.1667/rr1904.1 · Cited by 68
Abscopal effect of radiation therapy: Interplay between radiation dose and p53 status
Strigari, L., Mancuso, M., Ubertini, V., Soriani, A., Giardullo, P., Benassi, M., D’Alessio, D., Leonardi, S., Soddu, S., & Bossi, G. (2013) · International Journal of Radiation Biology · doi:10.3109/09553002.2014.874608 · Cited by 67
An In Situ Autologous Tumor Vaccination with Combined Radiation Therapy and TLR9 Agonist Therapy
Zhang, H., Liu, L., Yu, D., Kandimalla, E. R., Sun, H. B., Agrawal, S., & Guha, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038111 · Cited by 66
Low-dose radiation enhances therapeutic HPV DNA vaccination in tumor-bearing hosts
Tseng, C.-W., Trimble, C. L., Zeng, Q., Monie, A., Alvarez, R. D., Huh, W. K., Hoory, T., Wang, M., Hung, C., & Wu, T. ‐. (2008) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-008-0596-0 · Cited by 62
Gupta, S., Koru‐Sengul, T., Arnold, S. M., Devi, G. R., Mohiuddin, M., & Ahmed, M. M. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0630 · Cited by 58
Alteration of cytokine profiles in mice exposed to chronic low-dose ionizing radiation
Shin, S. C., Lee, K., Kang, Y. M., Kim, K., Kim, C. S., Yang, K. H., Jin, Y.-W., Kim, C. S., & Kim, H. S. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.05.121 · Cited by 56
Balducci, M., Chiesa, S., Diletto, B., D’Agostino, G. R., Mangiola, A., Manfrida, S., Mantini, G., Albanese, A., Fiorentino, A., Frascino, V., et al. (2011) · Neuro-Oncology · doi:10.1093/neuonc/nor173 · Cited by 53
CpG oligodeoxynucleotides are potent enhancers of radio- and chemoresponses of murine tumors
Mason, K. A., Neal, R. E., Hunter, N. R., Ariga, H., Ang, K. K., & Milas, L. (2006) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2006.07.024 · Cited by 52
Cao, M., Cabrera, R., Xu, Y., Liu, C., & Nelson, D. R. (2010) · International Journal of Radiation Biology · doi:10.3109/09553002.2010.518208 · Cited by 51
Kunos, C. A., Sill, M. W., Buekers, T., Walker, J. L., Schilder, J. M., Yamada, S. D., Waggoner, S. E., Mohiuddin, M., & Fracasso, P. M. (2010) · Gynecologic Oncology · doi:10.1016/j.ygyno.2010.10.018 · Cited by 51
Qinfeng, S., Wang, D., Xiaofeng, Y., Shah, W., Hongwei, C., & Yili, W. (2013) · Radiation Research · doi:10.1667/rr3155.1 · Cited by 45
Tabi, Z., Spary, L. K., Coleman, S. L., Clayton, A., Mason, M. D., & Staffurth, J. N. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000488 · Cited by 40
Radio-responsive tumors exhibit greater intratumoral immune activity than nonresponsive tumors
Gerber, S. A., Lim, J. Y. H., Connolly, K. A., Sedlacek, A. L., Barlow, M. L., Murphy, S. P., Egilmez, N. K., & Lord, E. M. (2013) · International Journal of Cancer · doi:10.1002/ijc.28558 · Cited by 37
Fujita, T., Teramoto, K., Ozaki, Y., Hanaoka, J., Tezuka, N., Itoh, Y., Asai, T., Fujino, S., Kontani, K., & Ogasawara, K. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2499 · Cited by 36
Pilones, K. A., Aryankalayil, J. B., Babb, J. S., & Demaria, S. (2014) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-014-0037-x · Cited by 34
Regulatory T Cells in γ Irradiation-Induced Immune Suppression
McFarland, H. I., Puig, M., Grajkowska, L. T., Tsuji, K., Lee, J. P., Mason, K. P., Verthelyi, D. I., & Rosenberg, A. S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039092 · Cited by 32
Response of Crypt Paneth Cells in the Small Intestine following Total-Body γ-Irradiation
Gorbunov, N. V., Garrison, B. R., & Kiang, J. G. (2010) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463201002300415 · Cited by 28
Mantini, G., Valentini, V., Meduri, B., Margaritora, S., Balducci, M., Miccichè, F., Nardone, L., Rose, F. D., Cesario, A., Larici, A. R., et al. (2012) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2012.09.006 · Cited by 24
Murakami, T., Tokunaga, N., Waku, T., Gomi, S., Kagawa, S., Tanaka, N., & Fujiwara, T. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0599 · Cited by 24
Intestinal Irradiation and Fibrosis in a Th1-Deficient Environment
Linard, C., Billiard, F., & Benderitter, M. (2012) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2011.11.027 · Cited by 23
Ionizing Radiation Selectively Reduces Skin Regulatory T Cells and Alters Immune Function
Zhou, Y., Ni, H., Balint, K., Sanzari, J. K., Dentchev, T., Diffenderfer, E. S., Wilson, J. M., Cengel, K. A., & Weissman, D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100800 · Cited by 16
Lerret, N. M., Rogozinska, M., Jaramillo, A., & Marzo, A. L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041240 · Cited by 8
Cited by
Reactive Oxygen Species (ROS)-Based Nanomedicine
Yang, B., Chen, Y., & Shi, J. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00626 · Cited by 2,443
Radiotherapy combined with immunotherapy: the dawn of cancer treatment
Zhang, Z., Liu, X., Chen, D., & Yu, J. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01102-y · Cited by 670
Tumor Microenvironment as A “Game Changer” in Cancer Radiotherapy
Jarosz-Biej, M., Smolarczyk, R., Cichoń, T., & Kułach, N. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133212 · Cited by 546
Manganese Oxide Nanomaterials: Synthesis, Properties, and Theranostic Applications
Ding, B., Zheng, P., Ma, P., & Lin, J. (2020) · Advanced Materials · doi:10.1002/adma.201905823 · Cited by 521
Ferroptosis, radiotherapy, and combination therapeutic strategies
Lei, G., Mao, C., Yan, Y., Zhuang, L., & Gan, B. (2021) · Protein & Cell · doi:10.1007/s13238-021-00841-y · Cited by 504
Metadata
- Authors
- Herrera, F. G., Bourhis, J., & Coukos, G.
- Venue
- CA: A Cancer Journal for Clinicians
- Publisher
- Wiley
- Published
- 2016-08-29
- Volume
- 67
- Issue
- 1
- Pages
- 65-85
- ISSN
- 0007-9235 (ISSN-L)
- 1542-4863
- OpenAlex
- W2512217706
- Cited by
- 509
- References
- 195
- FWCI
- 16.53
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.